Valour Ethereum Zero [ETH0E] vs Pharming Group N.V [PHARM] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Valour Ethereum Zero wins in 5 metrics, Pharming Group N.V wins in 9 metrics, with 0 ties. Pharming Group N.V appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricValour Ethereum ZeroPharming Group N.VBetter
P/E Ratio (TTM)-48.4157.15Valour Ethereum Zero
Price-to-Book Ratio11.673.29Pharming Group N.V
Debt-to-Equity Ratio0.2453.57Valour Ethereum Zero
PEG RatioN/A-115.10N/A
EV/EBITDA-69.4528.49Valour Ethereum Zero
Profit Margin (TTM)3.43%-2.41%Valour Ethereum Zero
Operating Margin (TTM)N/A3.27%N/A
EBITDA Margin (TTM)N/A3.27%N/A
Return on Equity-13.20%-3.70%Pharming Group N.V
Return on Assets (TTM)-12.92%2.85%Pharming Group N.V
Free Cash Flow (TTM)N/A$-2.22MN/A
1-Year Return31.27%57.53%Pharming Group N.V
Price-to-Sales Ratio (TTM)64.112.32Pharming Group N.V
Enterprise Value$285.97M$644.82MPharming Group N.V
EV/Revenue Ratio55.522.21Pharming Group N.V
Gross Profit Margin (TTM)1.63%90.38%Pharming Group N.V
Revenue per Share (TTM)$1$1Valour Ethereum Zero
Earnings per Share (Diluted)$-0.79$-0.01Pharming Group N.V
Beta (Stock Volatility)N/A0.54N/A
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Valour Ethereum Zero vs Pharming Group N.V Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Valour Ethereum Zero0.00%0.00%24.89%60.40%45.34%11.78%
Pharming Group N.V5.31%15.00%36.90%22.34%29.21%19.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Valour Ethereum Zero31.27%1,102.52%565.04%565.04%565.04%565.04%
Pharming Group N.V57.53%1.77%8.49%283.33%-27.22%-96.70%

Performance & Financial Health Analysis: Valour Ethereum Zero vs Pharming Group N.V

MetricETH0EPHARM
Market Information
Market Cap i€330.22M€788.61M
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i29914,295,946
90 Day Avg. Volume i27912,484,792
Last Close€38.24€1.15
52 Week Range€13.50 - €40.89€0.65 - €1.16
% from 52W High-6.48%-1.03%
All-Time High€40.89 (Aug 14, 2025)€459.55 (Jul 10, 2000)
% from All-Time High-6.48%-99.75%
Growth Metrics
Quarterly Revenue Growth-0.42%0.26%
Quarterly Earnings GrowthN/A0.08%
Financial Health
Profit Margin (TTM) i0.03%-0.02%
Operating Margin (TTM) iN/A0.03%
Return on Equity (TTM) i-0.13%-0.04%
Debt to Equity (MRQ) i0.2453.57
Cash & Liquidity
Book Value per Share (MRQ)€2.94€0.35
Cash per Share (MRQ)€3.17€0.18
Operating Cash Flow (TTM) i€-2,327,570€26.65M
Levered Free Cash Flow (TTM) i€46.07M€19.90M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Valour Ethereum Zero vs Pharming Group N.V

MetricETH0EPHARM
Price Ratios
P/E Ratio (TTM) i-48.4157.15
Forward P/E iN/A-115.10
PEG Ratio iN/A-115.10
Price to Sales (TTM) i64.112.32
Price to Book (MRQ) i11.673.29
Market Capitalization
Market Capitalization i€330.22M€788.61M
Enterprise Value i€285.97M€644.82M
Enterprise Value Metrics
Enterprise to Revenue i55.522.21
Enterprise to EBITDA i-69.4528.49
Risk & Other Metrics
Beta iN/A0.54
Book Value per Share (MRQ) i€2.94€0.35

Financial Statements Comparison: Valour Ethereum Zero vs Pharming Group N.V

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ETH0EPHARM
Revenue/Sales iN/A€79.50M
Cost of Goods Sold iN/A€7.65M
Gross Profit iN/A€71.85M
Research & Development iN/A€20.21M
Operating Income (EBIT) iN/A€7.68M
EBITDA iN/A€8.34M
Pre-Tax Income iN/A€6.04M
Income Tax iN/A€2.16M
Net Income (Profit) iN/A€3.88M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ETH0EPHARM
Cash & Equivalents iN/A€78.54M
Total Current Assets iN/A€209.60M
Total Current Liabilities iN/A€75.00M
Long-Term Debt iN/A€101.28M
Total Shareholders Equity iN/A€204.29M
Retained Earnings iN/A€-243.93M
Property, Plant & Equipment iN/A€20.95M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ETH0EPHARM
Operating Cash Flow iN/A€10.25M
Capital Expenditures iN/AN/A
Free Cash Flow iN/A€9.97M
Debt Repayment iN/A€-915,054
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricETH0EPHARM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i29914,295,946
Average Daily Volume (90 Day) i27912,484,792
Shares Outstanding i8.63M583.98M
Float Shares iN/A670.71M
% Held by Insiders iN/A0.01%
% Held by Institutions iN/A0.13%

Dividend Analysis & Yield Comparison: Valour Ethereum Zero vs Pharming Group N.V

MetricETH0EPHARM
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A